Pituitary, Thyroid & Adrenal Disorders
Latest News
Radioactive iodine can be first-line for hyperthyroidism, says UK
“Recommending the use of radioactive iodine as first-line treatment for adults with Graves’ disease is a change to current practice.”
News
Teprotumumab gets FDA go-ahead for thyroid eye disease
It is the first drug to be approved for treatment of the debilitating, autoimmune condition.
News
FDA panel okays teprotumumab for thyroid eye disease
Until now, the disease that has not really been treatable, with current treatment aimed at relief of symptoms.
Conference Coverage
Iscalimab normalizes thyroid hormone levels in some patients with Graves disease
CHICAGO – Patients with lower antibody levels and smaller thyroid volume were more likely to respond.
Latest News
Drug recall in U.S. causes extreme hardship for hypoparathyroid patients
Approximately 2,700 patients in the United States have been affected by the recall of Natpara.
Conference Coverage
Bethesda system underpredicts malignancy in pediatric thyroid tumors
CHICAGO – Malignancy was more likely in pediatric patients, especially for indeterminate nodules.
Conference Coverage
Findings confirm link between methimazole and risk for acute pancreatitis
CHICAGO – However, there is no evidence of a cumulative dose effect.
Latest News
Multimodal therapies almost double survival in anaplastic thyroid cancer
CHICAGO – One cancer center’s experience shows that a targeted, multidisciplinary approach makes a difference.
Latest News
Small nodules, big problems: AI's role in thyroid nodule diagnosis
A novel algorithm for benign thyroid nodules showed good sensitivity and specificity.
Latest News
Opioid-free regimen after neck dissection keeps patients comfortable
CHICAGO – A multimodal approach can also help reduce waste and the potential for addiction.
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.